Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 1
2011 1
2012 2
2013 1
2014 1
2015 2
2016 4
2017 3
2018 7
2019 5
2020 6
2021 13
2022 15
2023 9
2024 15
2025 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
In Reply.
Brandi G, Deserti M, Vasuri F, Farioli A, Degiovanni A, Palloni A, Frega G, Barbera MA, de Lorenzo S, Garajova I, Di Marco M, Pinna AD, Cescon M, Cucchetti A, Ercolani G, D'Errico-Grigioni A, Pantaleo MA, Biasco G, Tavolari S. Brandi G, et al. Among authors: garajova i. Oncologist. 2016 Dec;21(12):e5-e6. doi: 10.1634/theoncologist.2016-0286. Epub 2016 Nov 2. Oncologist. 2016. PMID: 27807301 Free PMC article.
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population.
Rimini M, Fornaro L, Rizzato MD, Antonuzzo L, Rossari F, Satake T, Vandeputte H, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Nichetti F, Chon HJ, Braconi C, Pirrone C, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Salani F, De Rosa A, Lavacchi D, Foti S, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Himmelsbach V, Landriscina M, Djaballah SA, Zanuso V, Masi G, Lonardi S, Rimassa L, Casadei-Gardini A. Rimini M, et al. Among authors: garajova i. Eur J Cancer. 2024 Sep;208:114199. doi: 10.1016/j.ejca.2024.114199. Epub 2024 Jun 30. Eur J Cancer. 2024. PMID: 39002348
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
Audisio A, Gallio C, Velenik V, Meillat H, Ruiz-Garcia E, Riesco MC, Alecha JS, Rasschaert G, Carvalho C, Randrian V, Kirac I, Hernando J, Artaç M, O'Connor JM, Waldhorn I, Braam PM, Shamseddine A, Moretto R, De la Pinta C, De Felice F, Dulskas A, Páez López-Bravo D, Vanden Bulcke A, Bock F, Deleporte A, Van Den Eynde M, Geboes KP, Loi M, Messina M, Houlzé-Laroye C, Puccini A, Pastorino A, Papamichael D, Fiore M, Sur D, Eid M, Antoun C, Salati M, Garajovà I, Jakubauskas M, Tomášek J, Sousa Pinto CM, Schwingel J, Morano F, Adams RA, Dermine A, Chau A, Javed MA, Ghidini M, Fiorica F, Montenegro P, Petrillo A, Spolverato G, Mulet Margalef N, Diaz M, Baratelli C, Puleo F, Karampeazis A, Sert F, Gilliaux Q, De Stefano A, Liberale G, Moretti L, Martinive P, Deltuvaite Thomas V, Staggs V, Saad ED, Van Laethem JL, Sclafani F; International Real-World TNT Study Consortium. Audisio A, et al. Among authors: garajova i. JAMA Oncol. 2025 Sep 1;11(9):1045-1054. doi: 10.1001/jamaoncol.2025.2026. JAMA Oncol. 2025. PMID: 40638097
Targeting Perineural Invasion in Pancreatic Cancer.
Garajová I, Giovannetti E. Garajová I, et al. Cancers (Basel). 2024 Dec 21;16(24):4260. doi: 10.3390/cancers16244260. Cancers (Basel). 2024. PMID: 39766161 Free PMC article. Review.
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study.
Rimini M, Masi G, Lonardi S, Nichetti F, Pressiani T, Lavacchi D, Jessica L, Giordano G, Scartozzi M, Tamburini E, Pastorino A, Rapposelli IG, Daniele B, Martinelli E, Garajova I, Aprile G, Schirripa M, Formica V, Salani F, Winchler C, Bergamo F, Balsano R, Gusmaroli E, Lorenzo A, Landriscina M, Pretta A, Toma I, Pirrone C, Diana A, Leone F, Brunetti O, Brandi G, Garattini SK, Satolli MA, Rossari F, Fornaro L, Niger M, Zanuso V, De Rosa A, Ratti F, Aldrighetti L, De Braud F, Foti S, Rizzato MD, Vivaldi C, Stefano C, Rimassa L, Antonuzzo L, Casadei-Gardini A. Rimini M, et al. Among authors: garajova i. Target Oncol. 2024 May;19(3):359-370. doi: 10.1007/s11523-024-01060-1. Epub 2024 May 1. Target Oncol. 2024. PMID: 38691295
Focus on Pancreatic Cancer Microenvironment.
Pratticò F, Garajová I. Pratticò F, et al. Among authors: garajova i. Curr Oncol. 2024 Jul 26;31(8):4241-4260. doi: 10.3390/curroncol31080316. Curr Oncol. 2024. PMID: 39195299 Free PMC article. Review.
Navigating the paradox of senescence and chemoresistance in pancreatic cancer.
Jeiroshi A, Deng J, Xu Z, Comandatore A, Xu G, Glaviano A, Morelli L, Garajova I, Giovannetti E. Jeiroshi A, et al. Among authors: garajova i. Semin Cancer Biol. 2025 Sep;114:60-72. doi: 10.1016/j.semcancer.2025.06.007. Epub 2025 Jun 11. Semin Cancer Biol. 2025. PMID: 40513693 Free article. Review.
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma.
Tovoli F, Pallotta DP, Vivaldi C, Campani C, Federico P, Palloni A, Dalbeni A, Soldà C, Lani L, Svegliati-Baroni G, Garajova I, Ielasi L, De Lorenzo S, Granito A, Stefanini B, Masi G, Marra F, Lonardi S, Brandi G, Daniele B, Auriemma A, Schiadà L, Chen R, Piscaglia F; ARTE study group. Tovoli F, et al. Among authors: garajova i. Dig Liver Dis. 2024 Dec;56(12):2079-2084. doi: 10.1016/j.dld.2024.07.035. Epub 2024 Aug 20. Dig Liver Dis. 2024. PMID: 39168753 Free article.
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab.
Stefanini B, Piscaglia F, Marra F, Iavarone M, Vivaldi C, Cabibbo G, Palloni A, Pressiani T, Dalbeni A, Stefanini B, Stella L, Federico P, Svegliati-Baroni G, Lonardi S, Soldà C, Ielasi L, De Lorenzo S, Garajova I, Campani C, Bruccoleri M, Masi G, Celsa C, Brandi G, Auriemma A, Daniele B, Ponziani FR, Lani L, Chen R, Boe M, Granito A, Rimassa L, Tovoli F; ARTE study group. Stefanini B, et al. Among authors: garajova i. Liver Cancer. 2025 May 26:1-14. doi: 10.1159/000545494. Online ahead of print. Liver Cancer. 2025. PMID: 40567390 Free PMC article.
95 results